Home > Healthcare > Analytical Instruments > Molecular Analysis > microarray scanners market
Get a free sample of Microarray Scanners Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Microarray Scanners Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Microarray scanners market size was valued at around USD 939.4 million in 2023 and is estimated to grow at 8.2% CAGR from 2024 to 2032. Microarray scanners are instruments used in genomics and molecular biology research to analyze microarrays, which are arrays of microscopic spots containing DNA, RNA, or protein molecules immobilized on a solid surface, such as a glass slide or silicon chip.
The primary function of a microarray scanner is to detect and quantify the fluorescent or luminescent signals emitted by the molecules on the microarray. This allows researchers to measure gene expression levels, identify genetic variations, study protein-protein interactions, and perform other high-throughput analyses.
The growing advancements in genomics and proteomics research is a significant driver for the microarray scanners market. Single-cell omics has emerged as a crucial tool to study cellular heterogeneity and understand the functional and morphological characteristics of individual cells within multicellular organisms. Further as per article published in National Library of Medicine in 2022, next-generation sequencing (NGS) technologies have seen notable progress in terms of faster and more accurate sequencing, reduced costs, and improved data analysis. These advancements hold great promise for various applications including microarray scanners.
Furthermore, increasing drug discovery services (market size is estimated to account for USD 61.6 billion by the end of year 2032), advancement in drug screening, increasing utilization of genomics services, government initiatives and funding, and increasing education & awareness, are the promoting factors advancing the growth of the market.
The fluorescence segment in the microarray scanners market will generate USD 806 million by 2032, backed by the high sensitivity and specificity, allowing accurate detection and quantification of fluorescently labeled molecules on microarrays.
Microarray scanners market size was valued at USD 939.4 million in 2023 and is estimated to grow at 8.2% CAGR from 2024 to 2032, owing to the growing technological advancements.
Agilent Technologies, Inc., Arrayit Corporation, Aushon BioSystems, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Hitachi High-Tech Corporation, Illumina, Inc., LI-COR Biosciences, Microarrays, Inc., Oxford Gene Technology, and PerkinElmer, Inc.
U.S. microarray scanners market size is anticipated to grow at 7.9% CAGR during 2024-2032, attributed to the high prevalence of chronic diseases, including cancer, diabetes, and hypertension.